Comparative Pharmacology
Head-to-head clinical analysis: MINTEZOL versus POVAN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MINTEZOL versus POVAN.
MINTEZOL vs POVAN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Thiabendazole inhibits the mitochondrial fumarate reductase system in susceptible helminths, disrupting energy metabolism.
Pyrvinium pamoate inhibits oxidative metabolism and glucose uptake in susceptible helminths, leading to energy depletion and paralysis of the worm. It also binds to DNA and inhibits RNA synthesis in the parasite.
50 mg/kg/day orally in 2-3 divided doses, maximum 3 g/day, for 2-3 days.
Pyrantel pamoate: 11 mg/kg (maximum 1 g) orally once; repeat in 2 weeks for pinworm. For ascariasis, hookworm, trichostrongyliasis: 11 mg/kg (max 1 g) once daily for 3 days.
None Documented
None Documented
Terminal elimination half-life: 2-8 hours (mean 4 hours). Hepatic impairment prolongs; dose adjustment recommended.
Terminal elimination half-life is approximately 16 hours; clinically, this supports single-dose administration with slow elimination
Renal: 90% within 24 hours (5% unchanged, 85% as metabolites). Fecal: <10%.
Primarily fecal (90%) as unchanged drug via bile; renal excretion is minimal (<1%)
Category C
Category C
Anthelmintic
Anthelmintic